Leslie D. Funtleyder - Jun 9, 2025 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Signature
/s/ Leslie D. Funtleyder
Stock symbol
APLT
Transactions as of
Jun 9, 2025
Transactions value $
$0
Form type
4
Date filed
7/3/2025, 08:00 AM
Previous filing
Mar 26, 2025
Next filing
Oct 1, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Funtleyder Leslie D. Chief Financial Officer, Director C/O APPLIED THERAPEUTICS, INC., 545 FIFTH AVENUE, SUITE 1400, NEW YORK /s/ Leslie D. Funtleyder 2025-07-03 0001775394

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +150K +23.54% $0.00 787K Jun 9, 2025 Direct F1, F2
transaction APLT Common Stock Award $0 +150K +19.06% $0.00 937K Jul 1, 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following April 1, 2025, subject to the Reporting Person continuing to provide services through each such date.
F2 The total holdings have been adjusted to correct an administrative error in prior Form 4s that resulted in the overstatement of the total holdings.
F3 Consists of compensatory RSUs granted under the Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following July 1, 2025, subject to the Reporting Person continuing to provide services through each such date.

Remarks:

Interim Chief Executive Officer and Chief Financial Officer